Clinical Trials Sponsored by Cristal Therapeutics
Total 9299 results
-
Wellstat TherapeuticsCompletedPancreatic Cancer | Drug/Agent Toxicity by Tissue/OrganUnited States, Canada
-
United TherapeuticsCompletedPulmonary Arterial Hypertension | Renal DysfunctionUnited States
-
Windtree TherapeuticsTerminatedMeconium AspirationUnited States
-
Pathfinder TherapeuticsCompletedLiver CancerUnited States
-
Chelsea TherapeuticsCompletedQTc IntervalUnited States
-
Corcept TherapeuticsCompletedDepressive Disorder, MajorUnited States
-
Pathfinder TherapeuticsCompletedLiver CancerUnited States
-
Chroma TherapeuticsCompletedSafety Study of the Histone Deacetylase Inhibitor, CHR-3996, in Patients With Advanced Solid TumoursSolid TumorNetherlands, United Kingdom
-
Mateon TherapeuticsCompleted
-
Aeris TherapeuticsCompleted
-
Acorda TherapeuticsCompletedMultiple SclerosisUnited States, Canada
-
Aegera TherapeuticsTerminatedLeukemiaUnited States, Canada, Germany
-
vTv TherapeuticsCompletedObesityUnited States, Canada
-
Harbor TherapeuticsCompletedType 2 Diabetes MellitusUnited States
-
Intarcia TherapeuticsCompletedChronic Hepatitis CUnited States, Puerto Rico
-
Precision TherapeuticsCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
United TherapeuticsCompletedPulmonary Arterial HypertensionUnited States
-
Chroma TherapeuticsCompletedAcute Myeloid Leukemia | Multiple Myeloma | Myelodysplastic SyndromeUnited Kingdom
-
Ascenta TherapeuticsCompletedHormone Refractory Prostate CancerUnited States
-
United TherapeuticsCompletedPulmonary Arterial HypertensionUnited States
-
DARA TherapeuticsCompleted
-
Celldex TherapeuticsCompletedBreast Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Bladder CancerUnited States
-
Celldex TherapeuticsCompletedBreast Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Bladder CancerUnited States
-
MediQuest TherapeuticsUnknownRaynaud DiseaseUnited States
-
Allergy TherapeuticsCompletedType I HypersensitivityGermany
-
Allergy TherapeuticsCompletedType I HypersensitivityCanada
-
Allergy TherapeuticsCompletedType I HypersensitivityCanada
-
Allergy TherapeuticsCompleted
-
Allergy TherapeuticsCompletedType I HypersensitivityUnited States
-
Aegera TherapeuticsCompletedChronic Pain | Diabetic Peripheral NeuropathyUnited States, Canada, Bulgaria, Romania
-
United TherapeuticsCompletedPulmonary Arterial Hypertension | Hypertension, PulmonaryUnited States
-
Arrow TherapeuticsCompleted
-
Arrow TherapeuticsCompletedRespiratory Syncytial Virus InfectionsUnited Kingdom
-
Aeris TherapeuticsCompletedChronic Obstructive Pulmonary Disease | Pulmonary EmphysemaIsrael
-
Aeris TherapeuticsWithdrawnAdvanced Upper Lobe Predominant Emphysema
-
Aegera TherapeuticsCompletedLeukemia, Myelomonocytic, AcuteUnited States, Canada
-
Aegera TherapeuticsTerminatedCarcinoma | PancreasUnited States
-
Critical TherapeuticsTerminatedAsthmaUnited States
-
Introgen TherapeuticsCompletedLocally Advanced Breast Cancer (LABC)United States
-
Aeris TherapeuticsCompletedPulmonary EmphysemaUnited States
-
ARYx TherapeuticsCompletedAtrial FibrillationUnited States
-
Critical TherapeuticsCompleted
-
Introgen TherapeuticsUnknownCarcinoma, Squamous CellUnited States
-
Intarcia TherapeuticsTerminatedBreast Neoplasms | Neoplasms, Hormone-DependentUnited States, Ukraine, Canada, Russian Federation
-
Intarcia TherapeuticsTerminatedBreast Neoplasms | Neoplasms, Hormone-DependentUnited States, Romania, Russian Federation, Ukraine, Bulgaria
-
MediQuest TherapeuticsCompletedRaynaud's DiseaseUnited States, Canada
-
ImaRx TherapeuticsTerminatedAcute Ischemic Stroke